The CUD cohort included 4, 648, cases and 4, 648 controls (n=9296) with mean age (53.1 vs
Unapproved products are risky not only because they havent been reviewed by the FDA, but because theres no way to know their potency, possible contamination, or potential dosing errors
She looks differentCurrently on the progesterone-only pill, as shes never been keen on LARCs and her weight precluded the COCP, she asks if she can now go on the combined pill as shes finding the breakthrough bleeding on the POP really annoying
The key question will be whether the pharmaceutical companies can attract enough users/patients for their very specialized offerings, or if patients will prefer the broader range of medications and treatments available through the more comprehensive IOPs
Published June 14, 2021
Lost in translation: challenges of current pharmacotherapy for sarcopenia